Collagen-Binding Synthetic Peptidoglycans for Matrix Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for engineering collagen matrices lack the ability to precisely control the structural and mechanical characteristics, as well as cellular responses, necessary for effective tissue engineering applications, due to limitations in influencing collagen fibrillogenesis and interactions with extracellular matrix components.
Innovation Solution
Development of collagen-binding synthetic peptidoglycans that combine synthetic peptides with glycosaminoglycans or polysaccharides, allowing for tailored influence on collagen organization, mechanical properties, and cellular behavior, by binding to collagen and altering the structure and function of engineered collagen matrices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to engineer collagen matrices, then the process is simple and easy to manufacture, but the ability to precisely control structural and mechanical characteristics is limited
Solution Approach 1:
The patent introduces synthetic peptidoglycans as intermediary molecules that mediate between collagen fibers and cellular responses. These peptidoglycans bind to collagen and modulate its structural organization, thereby providing precise control over matrix characteristics without requiring complex engineering processes. The peptidoglycans act as molecular mediators that translate simple mixing protocols into controlled structural outcomes.
Solution Approach 2:
The patent employs parameter changes by varying the amino acid sequence, glycan composition, and molecular weight of synthetic peptidoglycans to achieve different structural and mechanical properties in collagen matrices. By changing these parameters of the peptidoglycan molecules, the patent can precisely control fibrillogenesis, matrix stiffness, and porosity using straightforward manufacturing methods.
2Adaptability or versatility
If collagen matrices are engineered without synthetic peptidoglycans, then the manufacturing process is simpler, but the ability to influence collagen fibrillogenesis and cellular responses is reduced
Solution Approach 1:
The synthetic peptidoglycans are designed with multi-functionality, serving as collagen-binding agents, fibrillogenesis modulators, and cellular response regulators simultaneously. This universal functionality allows a single molecule type to achieve multiple objectives in collagen matrix engineering, enhancing adaptability without proportionally increasing system complexity.
Solution Approach 2:
The patent creates composite collagen-peptidoglycan materials that combine the structural properties of collagen with the functional capabilities of synthetic peptidoglycans. This composite approach enables precise control over collagen organization and cellular interactions by integrating two material systems with complementary functions, achieving high adaptability while maintaining manageable complexity through well-defined composition ratios.
3Strength
If traditional collagen matrix methods are used, then the material composition remains simple, but the mechanical integrity and biological signals for cell growth are insufficient
Solution Approach 1:
The patent merges collagen with synthetic peptidoglycans in a unified matrix system, combining the mechanical support function of collagen with the biological signaling capabilities of peptidoglycans. This merging creates a synergistic effect where the composite material exhibits enhanced mechanical integrity and biological activity compared to either component alone, achieving improved strength without requiring large quantities of additional substances.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of collagen-binding synthetic peptidoglycans enables the creation of engineered collagen matrices with specific structural, mechanical, and biological characteristics, enhancing tissue engineering applications by modifying fibrillogenesis and cellular interactions, thereby improving tissue regeneration and remodeling.
Implementation Method 1
collagen-binding synthetic peptidoglycans which influence collagen organization at the molecular level. These collagen-binding synthetic peptidoglycans are designed based on collagen binding peptides attached to, for example, a glycan
Implementation Method 2
The collagen-binding synthetic peptidoglycans described herein influence the morphological, mechanical, and biological characteristics of collagen matrices
Data Source
AI summary
This invention relates to collagen-binding synthetic peptidoglycans and engineered collagen matrices comprising a collagen matrix and a collagen-binding synthetic peptidoglycan where the collagen-binding synthetic peptidoglycan can be aberrant or can have amino acid homology with a portion of the amino acid sequence of a protein or a proteoglycan that regulates collagen fibrillogenesis. The invention also relates to kits, compounds, compositions, and engineered graft constructs comprising such collagen-binding synthetic peptidoglycans or engineered collagen matrices and methods for their preparation and use.